The actions of bismuth in the treatment of Helicobacter pylori infection.
about
Pathogenesis of Helicobacter pylori infectionSolubility, absorption, and anti-Helicobacter pylori activity of bismuth subnitrate and colloidal bismuth subcitrate: In vitro data Do not predict In vivo efficacy.Competitive binding of bismuth to transferrin and albumin in aqueous solution and in blood plasma.Treatment of Helicobacter pylori infection: current status and future concepts.Definitions of reflux disease and its separation from dyspepsiaShort course acid suppressive treatment for patients with functional dyspepsia: results depend on Helicobacter pylori status. The Frosch Study Group.Bismuth ions inhibit the biological activity of non-amidated gastrins in vivo.Pylera for the eradication of Helicobacter pylori infection.The actions of bismuth in the treatment of Helicobacter pylori infections: an update.Current and potential applications of bismuth-based drugs.Role of bismuth in improving Helicobacter pylori eradication with triple therapy.Eradication of Helicobacter pylori Infection.Bismuth(III) β-thioxoketonates as antibiotics against Helicobacter pylori and as anti-leishmanial agents.A novel effect of bismuth ions: selective inhibition of the biological activity of glycine-extended gastrin.The action of bismuth against Helicobacter pylori mimics but is not caused by intracellular iron deprivationColloidal bismuth subcitrate impedes proton entry into Helicobacter pylori and increases the efficacy of growth-dependent antibiotics.First-line Bismuth-containing Five-day Concomitant Quintuple Therapy for Helicobacter Pylori Eradication.Bismuth-inhibitory effects on bacteria and stimulation of fungal growth in vitro.Bismuth-containing single-antibiotic 1-week triple therapy for Helicobacter pylori eradication.Dispersive Liquid-Liquid Microextraction of Bismuth in Various Samples and Determination by Flame Atomic Absorption Spectrometry.Pharmacokinetics and bioequivalence of ranitidine and bismuth derived from two compound preparations.Bismuth-induced lysosomal rupture in J774 cells.Inhibition of fumarase by bismuth(III): implications for the tricarboxylic acid cycle as a potential target of bismuth drugs in Helicobacter pylori.Bismuthπ arene versus bismuthhalide coordination in heterocyclic diorganobismuth(iii) compounds with transannular N→Bi interaction.The efficacy of bismuth containing quadruple therapy as a first-line treatment option for Helicobacter pylori.The effects of EF-Ts and bismuth on EF-Tu in Helicobacter pylori: implications for an elegant timing for the introduction of EF-Ts in the elongation and EF-Tu as a potential drug target.Bismuth(III) deferiprone effectively inhibits growth of Desulfovibrio desulfuricans ATCC 27774.
P2860
Q24679810-A7310CF9-3AAA-4FB3-958B-9256CB418BB0Q30611002-7B4FB439-167C-458D-AA3C-85AF502E90F0Q30620709-90FE821B-3EC6-4138-AF6B-D00C956E6666Q33594850-9702C768-D53B-4C57-B8E6-A1FD4B57DBC3Q34601043-315EF0FC-4AAA-4DEF-BEA5-1B6CD6608CBFQ35361544-6CF9EC81-C39B-431C-AF69-FF216DF5E8C2Q35675367-826EB147-4F8F-42E9-9C52-1BCB26B16556Q37593096-9121977D-3B6F-42DF-9B94-F57D880740F3Q37987429-A311B913-A0AE-45FD-8280-0B12447EC02FQ38253836-C710F176-AE35-4DF4-A886-21E8F44BF091Q38723877-95089A9B-A4A9-4DD0-8BFF-CF14A7E70056Q38833959-A9285F3F-D40A-476D-B68B-34EB66BC5DEAQ39067074-D99DFBC6-D448-4D4E-82BA-8833CC57D86CQ40628633-F493EBDB-413E-448B-A018-34378A387E04Q40882735-B20DA41B-6D7E-461F-B922-036B72F4002BQ41074387-605149C3-3F47-4D37-B4D6-6F9C4066B540Q41143975-B5DFB83E-4354-4AE2-BA13-008B4C0E3220Q41904581-A5DE0AD8-A80E-4F62-AE4F-09F3B89F16D9Q42542863-F3038D6B-5CA0-493B-ADDD-723388012C88Q42544454-85D6CF77-DF2B-4869-8290-101E69054498Q42787535-5066E2AC-21CD-452B-87BC-DAAB012262B9Q44036329-7F961677-BF43-42FC-AC97-5018631CB528Q46194792-E656A063-5E35-418E-9C18-0333BD421DB9Q46408127-B662EEE0-BE93-4690-A12C-8D4FB0B1CC8DQ46923478-EAB9FF60-7F41-4BBE-8857-C85A78ED7996Q50909415-656A39DF-6C6A-4B87-83AC-13BE43AFB498Q51545806-50560885-2ABC-40C8-B916-1AB6B1F108F0
P2860
The actions of bismuth in the treatment of Helicobacter pylori infection.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
The actions of bismuth in the treatment of Helicobacter pylori infection.
@en
type
label
The actions of bismuth in the treatment of Helicobacter pylori infection.
@en
prefLabel
The actions of bismuth in the treatment of Helicobacter pylori infection.
@en
P1476
The actions of bismuth in the treatment of Helicobacter pylori infection.
@en
P2093
P356
10.1046/J.1365-2036.11.S1.13.X
P407
P478
11 Suppl 1
P577
1997-04-01T00:00:00Z